Transactions

Transactions

Rok Master Resources

Private Placement

$1,000,000

April 2014
Nuva Pharm

Private Placement

$375,000

April 2014
Antibe Therapeutics

Private Placement

$3,925,358

April 2014
Antibe Therapeutics

Private Placement

$1,250,000

January 2014
Diamedica

Prospectus Offering

$2,600,000

December 2013
Theralase

Private Placement

$3,150,000

November 2013
Verisante Technology

Prospectus Offering

$1,053,800

November 2013
Antibe Therapeutics

Initial Public Offering

$3,000,000

August 2013
Medallion Resources

Private Placement

$400,000

June 2013
Nuva Pharmaceuticals

Private Placement

$800,000

June 2013
iCo Therapeutics

Overnight Offering

$3,200,000

May 2013
Kane Biotech

Private Placement

$1,442,800

December 2012
Rok Master Resources

Private Placement

$1,530,000

September 2012
iCo Therapeutics

Overnight Offering

$2,550,000

July 2012
Altair Gold

Private Placement

$1,934,051.24

April 2012
biOasis Technologies Inc.

Private Placement

$2,484,000

April 2012
Abattis Biologix Corp.

Private Placement

$300,000

January 2012
biOasis Technologies Inc.

Private Placement

$1,157,374

December 2011
iCo Therapeutics

Private Placement

$1,115,000

November 2011
Kane Biotech Inc.

Private Placement

$2,391,159

April 2011
Abattis Biologix Corp.

Share Purchase

$160,000

March 2011
biOasis Technologies Inc.

Private Placement

$1,029,287

November 2010
Sama Resources Inc.

Private Placement

$3,000,000

August 2010
Sama Resources Inc

Private Placement

$1,200,000

March 2010
Kane Biotech Inc.

Private Placement

$563,615

December 2009
Chemaphor Inc.

Private Placement

$1,264,877

October 2009
iCo Therapeutics Inc.

Private Placement

$475,000

July 2009
iCo Therapeutics Inc.

Private Placement

$1,292,500

February 2009
Medicago Inc.

Private Placement

$2,210,000

August 2008
Medicago Inc.

Private Placement

$2,600,000

March 2008
Energulf Resources Inc.

Private Placement

$8,800,000

January 2008
ALDA Pharmaceuticals Corp.

Private Placement

$250,000